Analyst Ratings For NYSE:EBS – Emergent Biosolutions (NYSE:EBS)
Today, Argus initiated coverage on NYSE:EBS – Emergent Biosolutions (NYSE:EBS) with a Buy with a price target of $62.00.
Some recent analyst ratings include
- 6/13/2018-Argus initiated coverage with a Buy rating.
- 6/11/2018-Cantor Fitzgerald initiated coverage with a Buy rating.
- 4/25/2018-Wells Fargo & Co Reiterated Rating of Outperform ➝ Market Perform.
- 1/24/2018-Goldman Sachs Group initiated coverage with a Neutral ➝ Neutral rating.
- 1/9/2017-Cowen Reiterated Rating of Hold.
Recent Insider Trading Activity For NYSE:EBS – Emergent Biosolutions (NYSE:EBS)
NYSE:EBS – Emergent Biosolutions (NYSE:EBS) has insider ownership of 13.40% and institutional ownership of 83.12%.
- On 6/11/2018 George A Joulwan, Director, sold 5,000 with an average share price of $52.89 per share and the total transaction amounting to $264,450.00.
- On 6/6/2018 Kathryn C Zoon, Director, sold 376 with an average share price of $52.81 per share and the total transaction amounting to $19,856.56.
- On 6/5/2018 Daniel Abdun-Nabi, CEO, sold 15,785 with an average share price of $52.11 per share and the total transaction amounting to $822,556.35.
- On 5/24/2018 Kathryn C Zoon, Director, sold 1,377 with an average share price of $51.15 per share and the total transaction amounting to $70,433.55.
- On 4/17/2018 Ronald Richard, Director, sold 7,893 with an average share price of $55.00 per share and the total transaction amounting to $434,115.00.
- On 3/12/2018 Adam Havey, EVP, sold 5,842 with an average share price of $52.82 per share and the total transaction amounting to $308,574.44.
- On 3/1/2018 Adam Havey, EVP, sold 1,898 with an average share price of $49.50 per share and the total transaction amounting to $93,951.00.
Recent Trading Activity for NYSE:EBS – Emergent Biosolutions (NYSE:EBS)
Shares of NYSE:EBS – Emergent Biosolutions closed the previous trading session at 54.27 up +0.53 0.99% with 54.90999984741211 shares trading hands.